IRIS
FERRO, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.325
EU - Europa 8.353
AS - Asia 4.030
SA - Sud America 1.453
Continente sconosciuto - Info sul continente non disponibili 186
AF - Africa 140
OC - Oceania 5
Totale 26.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.113
RU - Federazione Russa 4.368
SG - Singapore 1.652
BR - Brasile 1.257
CN - Cina 1.140
IE - Irlanda 1.012
SE - Svezia 870
IT - Italia 431
HK - Hong Kong 430
UA - Ucraina 396
DE - Germania 337
VN - Vietnam 335
FR - Francia 256
GB - Regno Unito 227
FI - Finlandia 214
IN - India 144
CA - Canada 100
AR - Argentina 79
MX - Messico 59
CZ - Repubblica Ceca 43
BD - Bangladesh 41
IQ - Iraq 41
BE - Belgio 38
PL - Polonia 37
TR - Turchia 37
ZA - Sudafrica 37
EC - Ecuador 31
JP - Giappone 29
MA - Marocco 29
CI - Costa d'Avorio 23
ES - Italia 23
CO - Colombia 22
UZ - Uzbekistan 22
NL - Olanda 21
ID - Indonesia 20
AT - Austria 17
PK - Pakistan 16
VE - Venezuela 14
PY - Paraguay 13
SA - Arabia Saudita 13
EG - Egitto 12
KE - Kenya 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
CR - Costa Rica 9
PE - Perù 9
UY - Uruguay 9
BO - Bolivia 8
JM - Giamaica 8
JO - Giordania 8
KG - Kirghizistan 8
OM - Oman 8
PH - Filippine 8
DO - Repubblica Dominicana 7
NP - Nepal 7
AZ - Azerbaigian 6
CH - Svizzera 6
KR - Corea 6
LV - Lettonia 6
DZ - Algeria 5
GR - Grecia 5
HN - Honduras 5
IR - Iran 5
KZ - Kazakistan 5
LK - Sri Lanka 5
MY - Malesia 5
PA - Panama 5
TN - Tunisia 5
AL - Albania 4
BY - Bielorussia 4
EE - Estonia 4
IL - Israele 4
MD - Moldavia 4
NO - Norvegia 4
RO - Romania 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BH - Bahrain 3
GT - Guatemala 3
HU - Ungheria 3
LB - Libano 3
LT - Lituania 3
LU - Lussemburgo 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
ET - Etiopia 2
GE - Georgia 2
NG - Nigeria 2
Totale 26.284
Salva come PNG Salva come JPEG
Città #
Dallas 5.026
Moscow 1.229
Ashburn 1.016
Dublin 1.010
Singapore 850
Jacksonville 783
Chandler 727
Nyköping 577
Beijing 449
Hong Kong 429
San Jose 361
Council Bluffs 304
The Dalles 234
Princeton 180
Los Angeles 175
Dearborn 170
Cambridge 167
Medford 160
Lauterbourg 157
Des Moines 135
Ann Arbor 127
Messina 123
Dong Ket 116
Boardman 108
São Paulo 88
Ho Chi Minh City 77
Buffalo 74
New York 65
Lancaster 60
Wilmington 49
Woodbridge 49
Guangzhou 45
Tianjin 45
Orem 44
Santa Clara 42
Hyderabad 41
Jinan 41
San Mateo 40
Pune 38
Redondo Beach 37
Brooklyn 36
Brussels 36
Munich 36
Hanoi 35
Belo Horizonte 34
Phoenix 34
Shenyang 34
Denver 33
Brasília 30
Brno 30
Frankfurt am Main 30
Catania 29
Rio de Janeiro 29
Nanjing 28
Chicago 25
Houston 25
Tokyo 25
Johannesburg 24
Montreal 24
Abidjan 23
Turku 23
Warsaw 23
Atlanta 22
Lappeenranta 22
Seattle 22
Tashkent 22
Baghdad 21
Düsseldorf 20
Haikou 20
Hebei 20
London 19
Milan 18
Porto Alegre 17
Shanghai 17
Hangzhou 16
Goiânia 15
Manchester 15
Ningbo 15
Zhengzhou 15
Chennai 14
Columbus 14
Guarulhos 14
Mexico City 14
Mumbai 14
Rome 14
Stockholm 14
Taizhou 14
Vienna 14
Curitiba 13
Da Nang 13
Guayaquil 13
Ottawa 13
San Francisco 13
Biên Hòa 12
Boston 12
Campinas 12
Fuzhou 12
Quito 12
Contagem 11
Haiphong 11
Totale 16.683
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 4.625
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 278
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 266
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 221
AMPA receptor antagonists: Synthesis and pharmacological evaluation 211
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 210
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 198
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 197
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 195
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 193
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 192
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors. 191
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 189
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 188
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 188
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 186
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors 181
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 178
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 176
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 175
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 173
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 172
Antiretroviral strategy using multi-target agents 172
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 170
Graphene Quantum Dots Based Systems As HIV Inhibitors 170
Combined ligand-based and target-based approach to design NR2B/NMDA receptor antagonists 168
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 168
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 168
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 167
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 167
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 166
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 166
Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75 165
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 165
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 164
Analysis of Italian regulations on pathways of care for patients in a vegetative or minimally conscious state 163
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 161
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 161
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 160
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 159
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 159
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 158
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 156
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 156
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 152
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 151
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 151
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 149
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 147
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 146
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 145
New indole derivatives as promising ligands for ifenprodil site of NR2B/NMDA receptors 145
Discovery of potent HIV-1 integrase strand transfer inhibitors: design and synthetic strategies 144
HIV-1 integrase strand-transfer inhibitors: design and synthetic strategies in the process of a lead optimization 144
Synthesis, Structure-Activity Relationship Studies, and X-ray Crystallographic Analysis of Arylsulfonamides as Potent Carbonic Anhydrase Inhibitors. 144
Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists 144
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series 143
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 143
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 143
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 143
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 143
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 143
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 142
Insight into the INSTIs binding mode: molecular modeling investigation and SAR studies 142
Probing Molecular Interactions between Human Carbonic Anhydrases (hCAs) and a Novel Class of Benzenesulfonamides 142
Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. 142
NOVEL N1-ARYL-2- ARYLTHIOACETAMIDOBENZIMIDAZOLES WERE EFFECTIVE AGAINST HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION IN VITRO 142
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase 141
Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 141
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 141
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 138
INTEGRASE STRAND TRANSFER INHIBITORS (INSTIs): SYNTHESIS AND ANTIVIRAL EFFETCS OF CHLORO-FLUORO SUBSTITUTIONS 137
Progettazione, Sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 137
Computational studies and synthetic approaches for the identification of new protein-protein interaction inhibitors (PPI) 137
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 136
Rational design, synthesis and evaluation of coumarin derivatives as protein-protein interaction inhibitors 136
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 135
Nuovi Antagonisti Non-Competitivi Del Recettore NMDA/NR2b: Design e Sintesi” 134
Identification of potent carbonic anhydrase inhibitors: synthesis, biological evaluation and enzyme-ligand x-ray studies 134
Microwave assisted organic synthesis (MAOS) of small molecules as potential HIV-1 integrase inhibitors. 133
Design, Synthesis and Biostructural Characterization of Carbonic Anhydrase Inhibitors 133
New potent and selective carbonic anhydrase inhibitors: synthesis, biological evaluation and X-ray studies 132
Synthesis and biological profile of new 1,2,3,4-tetrahydroisoquinolines as selective carbonic anhydrase inhibitors 132
Synthesis and biological characterization of novel potent arylsulfonamides as human carbonic anhydrase inhibitors (hCAIs) targeting central nervous system 132
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 132
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 131
Synthesis of new potential HIV-1 integrase inhibitors 131
Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: Synthesis, biological evaluation, and molecular modeling studies 131
Sintesi e SAR di nuovi inibitori dell'acetilcolinesterasi come potenziali agenti anti-Alzheimer 130
Identification of 3-substituted-1H-indoles as ligands of GluN2B containing N-methyl-D-aspartate receptors 130
Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors 129
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 128
HIV-1-IN Strand-Transfer Inhibitors: phenyl ring exploration and synthesis of 1H-benzylindole derivative through fluorine substitutions 127
Searching for NR2B/NMDA Receptor Antagonists As Neuroprotective Agents 126
Synthesis, biological evaluation and docking studies of NR2B/NMDA receptor antagonists 124
Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screening 124
N-Substituted Isoquinoline Derivatives as Potential AChE Inhibitors 124
ISOQUINOLINE-SULFONAMIDES AS A CLASS OF POTENT AND SELECTIVE CARBONIC ANHYDRASE INHIBITORS 120
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 119
Synthesis and Biological Characterization of 3-Substituted-1H-indoles as Ligands of GluN2B-Containing N-Methyl-d-aspartate Receptors 115
Totale 20.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.542
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.542
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022864 0 0 0 48 38 11 81 39 28 11 258 350
2022/20232.901 242 254 143 218 212 297 54 148 1.232 8 74 19
2023/2024682 57 102 50 134 56 124 7 16 1 56 14 65
2024/20253.163 59 46 59 181 109 123 53 728 804 185 277 539
2025/202613.954 363 1.970 3.725 886 780 2.210 1.070 1.224 1.145 336 123 122
2026/20271.215 139 298 341 437 0 0 0 0 0 0 0 0
Totale 26.492